Yes, an APRN can prescribe controlled substances in every state, but the authority is layered. You need three things in place before you write a single prescription: state authorization under your APRN license, a current federal DEA registration, and completion of the MATE Act training. What you can actually prescribe, and whether you need a physician involved, depends on your state’s practice model and the drug’s federal schedule.
What Your State Decides
The DEA classifies nurse practitioners, certified nurse-midwives, certified registered nurse anesthetists, and clinical nurse specialists as “mid-level practitioners” who may dispense controlled substances when “authorized by their state.”1Diversion Control Division. Mid-Level Practitioners Authorization by State That phrase does most of the work. Federal law sets the floor, but your state decides whether you prescribe independently, under a collaborative agreement, or with direct supervision.
States generally follow one of three models. Full practice authority states let an APRN evaluate, diagnose, and prescribe (including controlled substances) with no mandatory physician involvement, under the board of nursing alone. Reduced practice states require a collaborative agreement with a physician, which may spell out allowed drug schedules, quantity caps, or chart-review obligations. Restricted practice states go further, sometimes requiring direct supervision or co-signatures.
A handful of states also limit APRN prescribing to Schedule III through V drugs, which means no independent prescribing of Schedule II medications like oxycodone or amphetamine salts. Because practice acts change often, check your state board of nursing’s current rules before assuming a particular privilege travels with your license.
The DEA Registration
State authority alone is not enough. Federal law requires every practitioner who dispenses or proposes to dispense controlled substances to register with the DEA.2govinfo. 21 USC 822 – Persons Required to Register APRNs file DEA Form 224 for a new registration and Form 224a to renew every three years. The most recently published practitioner fee is $888 per three-year cycle, set by a 2020 DEA rule.3Federal Register. Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants
Your DEA registration sits on top of your state credentials and depends on them. The DEA requires state licensing to be in order before issuing a registration, and if your state nursing license lapses or is revoked, your DEA number effectively becomes invalid. Many states also require a separate state-level controlled substance registration.4Diversion Control Division. Practitioner’s State License Requirements So you may be juggling three credentials at once: your APRN license, a state controlled substance certificate, and your federal DEA registration.
MATE Act Training
Since June 2023, every DEA-registered practitioner other than veterinarians must complete a one-time, eight-hour training on treating and managing patients with opioid and other substance use disorders. The requirement comes from the Medication Access and Training Expansion (MATE) Act.5Diversion Control Division. Opioid Use Disorder – MATE Act You attest to completing it when you apply for a new DEA registration or renew an existing one. Training you completed before June 2023 counts if it covered the required content. This is a one-time obligation, though your state may impose its own pharmacology continuing education for license renewal.
What You Can Prescribe at Each Schedule
Federal law sorts controlled substances into five schedules based on abuse potential and accepted medical use, and those schedule rules apply to APRNs the same way they apply to physicians.6Drug Enforcement Administration. Drug Scheduling
Schedule II
These carry the tightest controls. Drugs include oxycodone, fentanyl, methylphenidate, and amphetamine salts. Prescriptions must be written (oral orders are allowed only in genuine emergencies), and federal law flatly prohibits refills.7Office of the Law Revision Counsel. 21 USC 829 – Prescriptions Each new supply requires a new prescription.
Federal rules do not cap the days’ supply on a single Schedule II prescription, and the DEA allows a practitioner to issue multiple prescriptions at one visit covering up to a 90-day total supply, provided each includes the earliest fill date and state law does not prohibit it.8Federal Register. Issuance of Multiple Prescriptions for Schedule II Controlled Substances Many states impose stricter opioid supply limits, and that is where APRNs most often trip up: assuming federal rules are the only rules.
Schedules III Through V
Buprenorphine sits at Schedule III, benzodiazepines at Schedule IV, and certain cough preparations at Schedule V. Prescriptions in these schedules can generally be phoned in, and refills are permitted up to five times within six months of the original date.7Office of the Law Revision Counsel. 21 USC 829 – Prescriptions They still require a valid DEA registration and a legitimate medical purpose.9eCFR. 21 CFR 1306.04 – Purpose of Issue of Prescription
Schedule I
Schedule I drugs (heroin, LSD) have no accepted medical use under federal classification and cannot be prescribed by anyone, physicians included.
Prescribing by Telehealth
The Ryan Haight Act ordinarily requires an in-person medical evaluation before a practitioner prescribes a controlled substance via telehealth. The DEA has repeatedly extended pandemic-era flexibilities that waive that requirement, and the most recent extension runs through December 31, 2026.10Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care
Under the temporary rules, DEA-registered practitioners can prescribe Schedule II through V controlled substances after an audio-video telemedicine encounter without a prior in-person visit. For buprenorphine and other Schedule III through V medications used to treat opioid use disorder, audio-only encounters are permitted. Standard requirements still apply: legitimate medical purpose, licensed practitioner, compliance with federal and state law.10Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care Permanent telemedicine rules, including a proposed Special Registration for Telemedicine, are still being developed, so telehealth-heavy APRN practices should track the regulatory calendar.
PDMP Checks and Electronic Prescribing
Nearly every state operates a Prescription Drug Monitoring Program that tracks filled controlled substance prescriptions, and most states now require prescribers to query the database before writing certain controlled substance prescriptions. Triggers vary: some states require a check before every prescription, others only for initial prescriptions or specific drug classes such as opioids.
If you treat Medicare Part D patients, a separate federal mandate applies. Under the SUPPORT Act, prescribers must electronically transmit at least 70% of their qualifying Schedule II through V prescriptions.11Centers for Medicare and Medicaid Services. CMS Electronic Prescribing for Controlled Substances Program CMS calculates compliance from Part D claims, so nothing is self-reported. Prescribers who write 100 or fewer qualifying controlled substance prescriptions during the measurement year receive an automatic exception.12Centers for Medicare and Medicaid Services. CMS EPCS Program Requirement At-A-Glance
What Happens When Prescribing Goes Wrong
Consequences escalate quickly. On the administrative side, the DEA can suspend or revoke your registration, and losing it ends your ability to manage any patient who needs a controlled substance. DEA agents may also request a “voluntary surrender” of your registration; signing carries the same practical effect as revocation without the procedural protections.
Civil penalties for improper recordkeeping or inadequate controls can reach $25,000 per violation. Knowing violations prosecuted criminally can bring up to one year in prison for a first offense and up to two years for a repeat.13Office of the Law Revision Counsel. 21 USC 842 – Prohibited Acts B
The most severe penalties are reserved for prescribing outside a legitimate medical purpose. A prescription issued outside the usual course of professional practice is not legally a prescription at all under federal regulations, and both the prescriber and any pharmacist who knowingly fills it face liability.9eCFR. 21 CFR 1306.04 – Purpose of Issue of Prescription Unlawful distribution of a Schedule II substance can carry up to 20 years in prison for a first offense, and 20 years minimum if a patient dies or suffers serious bodily injury.14Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A These are the same penalties that apply to physicians. Federal prosecutors do not treat APRNs differently.
Steps To Start Prescribing
Confirm that your state APRN license authorizes controlled substance prescribing and identify whether your state requires a collaborative practice agreement. Apply for any state-level controlled substance certificate your state requires. Complete the eight-hour MATE Act training if you have not already. Then submit DEA Form 224, which requires proof of your state credentials.
Once registered, make sure your EHR supports electronic prescribing of controlled substances if you see Medicare patients, and set up PDMP access with a clear understanding of when your state requires you to query it. Keep every credential current, because your DEA number and state controlled substance certificate collapse the moment your state nursing license lapses. Calendaring all three renewal dates together is the simplest way to prevent an accidental gap.